These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals. Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707 [TBL] [Abstract][Full Text] [Related]
4. Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants. Buyel JF; Fischer R Biotechnol J; 2014 Apr; 9(4):566-77. PubMed ID: 24478119 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of robust host cell protein clearance in biopharmaceutical downstream processes. Shukla AA; Jiang C; Ma J; Rubacha M; Flansburg L; Lee SS Biotechnol Prog; 2008; 24(3):615-22. PubMed ID: 18410156 [TBL] [Abstract][Full Text] [Related]
6. High-throughput process development: I. Process chromatography. Rathore AS; Bhambure R Methods Mol Biol; 2014; 1129():29-37. PubMed ID: 24648064 [TBL] [Abstract][Full Text] [Related]
7. Separation science is the key to successful biopharmaceuticals. Guiochon G; Beaver LA J Chromatogr A; 2011 Dec; 1218(49):8836-58. PubMed ID: 21982447 [TBL] [Abstract][Full Text] [Related]
8. Designing new monoclonal antibody purification processes using mixed-mode chromatography sorbents. Toueille M; Uzel A; Depoisier JF; Gantier R J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Apr; 879(13-14):836-43. PubMed ID: 21439915 [TBL] [Abstract][Full Text] [Related]
9. Rational and systematic protein purification process development: the next generation. Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300 [TBL] [Abstract][Full Text] [Related]
10. Continuous downstream processing of biopharmaceuticals. Jungbauer A Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674 [TBL] [Abstract][Full Text] [Related]
11. Optimal synthesis of chromatographic trains for downstream protein processing. Polykarpou EM; Dalby PA; Papageorgiou LG Biotechnol Prog; 2011; 27(6):1653-60. PubMed ID: 21976368 [TBL] [Abstract][Full Text] [Related]
13. Efficient MILP formulations for the optimal synthesis of chromatographic protein purification processes. Vásquez-Alvarez E; Pinto JM J Biotechnol; 2004 Jun; 110(3):295-311. PubMed ID: 15163520 [TBL] [Abstract][Full Text] [Related]
14. Protein purification: an overview. Labrou NE Methods Mol Biol; 2014; 1129():3-10. PubMed ID: 24648062 [TBL] [Abstract][Full Text] [Related]
15. High-throughput process development for recombinant protein purification. Rege K; Pepsin M; Falcon B; Steele L; Heng M Biotechnol Bioeng; 2006 Mar; 93(4):618-30. PubMed ID: 16369981 [TBL] [Abstract][Full Text] [Related]
16. Multimodal chromatography: an efficient tool in downstream processing of proteins. Kallberg K; Johansson HO; Bulow L Biotechnol J; 2012 Dec; 7(12):1485-95. PubMed ID: 23139192 [TBL] [Abstract][Full Text] [Related]
17. Applying high-throughput methods to develop a purification process for a highly glycosylated protein. Sanaie N; Cecchini D; Pieracci J Biotechnol J; 2012 Oct; 7(10):1242-55. PubMed ID: 22899660 [TBL] [Abstract][Full Text] [Related]
18. Quantitative high throughput analytics to support polysaccharide production process development. Noyes A; Godavarti R; Titchener-Hooker N; Coffman J; Mukhopadhyay T Vaccine; 2014 May; 32(24):2819-28. PubMed ID: 24576849 [TBL] [Abstract][Full Text] [Related]
19. Multi-dimensional fractionation and characterization of crude protein mixtures: toward establishment of a database of protein purification process development parameters. Nfor BK; Ahamed T; Pinkse MW; van der Wielen LA; Verhaert PD; van Dedem GW; Eppink MH; van de Sandt EJ; Ottens M Biotechnol Bioeng; 2012 Dec; 109(12):3070-83. PubMed ID: 22688729 [TBL] [Abstract][Full Text] [Related]